These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 10665907)

  • 1. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas.
    North PE; Waner M; Mizeracki A; Mihm MC
    Hum Pathol; 2000 Jan; 31(1):11-22. PubMed ID: 10665907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta.
    North PE; Waner M; Mizeracki A; Mrak RE; Nicholas R; Kincannon J; Suen JY; Mihm MC
    Arch Dermatol; 2001 May; 137(5):559-70. PubMed ID: 11346333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of GLUT1 as a diagnostic marker in cutaneous vascular anomalies: A review of literature and recommendations for daily practice.
    van Vugt LJ; van der Vleuten CJM; Flucke U; Blokx WAM
    Pathol Res Pract; 2017 Jun; 213(6):591-597. PubMed ID: 28552538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital nonprogressive hemangioma: a distinct clinicopathologic entity unlike infantile hemangioma.
    North PE; Waner M; James CA; Mizeracki A; Frieden IJ; Mihm MC
    Arch Dermatol; 2001 Dec; 137(12):1607-20. PubMed ID: 11735711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capillary hemangioma of the central nervous system: a comparative study with lobular capillary hemangioma of the skin.
    Abe M; Misago N; Tanaka S; Masuoka J; Tabuchi K
    Acta Neuropathol; 2005 Feb; 109(2):151-8. PubMed ID: 15365728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLUT1 endothelial reactivity distinguishes hepatic infantile hemangioma from congenital hepatic vascular malformation with associated capillary proliferation.
    Mo JQ; Dimashkieh HH; Bove KE
    Hum Pathol; 2004 Feb; 35(2):200-9. PubMed ID: 14991538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomolecular markers and involution of hemangiomas.
    Frischer JS; Huang J; Serur A; Kadenhe A; Yamashiro DJ; Kandel JJ
    J Pediatr Surg; 2004 Mar; 39(3):400-4. PubMed ID: 15017560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updated classification of hemangiomas and other vascular anomalies.
    Chang MW
    Lymphat Res Biol; 2003; 1(4):259-65. PubMed ID: 15624554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma.
    Debelenko LV; Perez-Atayde AR; Mulliken JB; Liang MG; Archibald TH; Kozakewich HP
    Mod Pathol; 2005 Nov; 18(11):1454-60. PubMed ID: 15920541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous vascular proliferation. Part II. Hyperplasias and benign neoplasms.
    Requena L; Sangueza OP
    J Am Acad Dermatol; 1997 Dec; 37(6):887-919; quiz 920-2. PubMed ID: 9418757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
    Folpe AL; Veikkola T; Valtola R; Weiss SW
    Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign vascular proliferations--an immunohistochemical and comparative study.
    Dyduch G; Okoń K; Mierzyński W
    Pol J Pathol; 2004; 55(2):59-64. PubMed ID: 15469208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The expression and role of glucose transporter-1 in infantile hemangioma].
    Yuan SM; Jiang HQ; Hong ZJ; Wang J; Hu XB; Ouyang TX; Xing X
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2007 Mar; 23(2):90-3. PubMed ID: 17554865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathologic study of pediatric vascular anomalies: a report of 117 cases].
    Niu HL; Zhou SY; Lin QQ; Yi P; Wang FH; Gao Q; Chen ZR; Xia JQ; Zheng HC; Zeng RX
    Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):252-7. PubMed ID: 27033389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemangiomas and angiosarcomas of the breast: diagnostic utility of cell cycle markers with emphasis on Ki-67.
    Shin SJ; Lesser M; Rosen PP
    Arch Pathol Lab Med; 2007 Apr; 131(4):538-44. PubMed ID: 17425381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical investigations of orbital infantile hemangiomas and adult encapsulated cavernous venous lesions (malformation versus hemangioma).
    Osaki TH; Jakobiec FA; Mendoza PR; Lee Y; Fay AM
    Ophthalmic Plast Reconstr Surg; 2013; 29(3):183-95. PubMed ID: 23584448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma.
    Lyons LL; North PE; Mac-Moune Lai F; Stoler MH; Folpe AL; Weiss SW
    Am J Surg Pathol; 2004 May; 28(5):559-68. PubMed ID: 15105642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of prox1, lymphatic endothelial nuclear transcription factor, in Kaposiform hemangioendothelioma and tufted angioma.
    Le Huu AR; Jokinen CH; Rubin BP; Mihm MC; Weiss SW; North PE; Dadras SS
    Am J Surg Pathol; 2010 Nov; 34(11):1563-73. PubMed ID: 20975337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma.
    Hung YP; Fletcher CD; Hornick JL
    Am J Surg Pathol; 2017 May; 41(5):596-606. PubMed ID: 28009608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of follicle-stimulating hormone receptor in vascular anomalies.
    Maclellan RA; Vivero MP; Purcell P; Kozakewich HP; DiVasta AD; Mulliken JB; Fishman SJ; Greene AK
    Plast Reconstr Surg; 2014 Mar; 133(3):344e-351e. PubMed ID: 24572879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.